An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of CLN3 Disease
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05174039 |
|
Recruitment Status :
Active, not recruiting
First Posted : December 30, 2021
Last Update Posted : April 26, 2024
|
Sponsor:
Beyond Batten Disease Foundation
Collaborator:
Theranexus
Information provided by (Responsible Party):
Beyond Batten Disease Foundation
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | May 15, 2024 |
| Estimated Study Completion Date : | August 15, 2024 |